English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Adjuvant chemotherapu (AC) is a treatment systematically applied under 50-year-old premenopausal women with node positive breast cancer. Ir is estimated that each year, in France, 2 500 patients are being treated using this procedure. A cost-utility analysis was performed assessing the efficacy and the cost of AC and its effects on the quality of life. Efficacy was measured using the R. Peto's meta-analysis of controlled trials where a compound of cyclophosphamide, methotrexate, fluorouracil was administered in the treatment group

Analyse coût-utilité en cancérologie. Application à la chimiothérapie adjuvante dans le traitement du cancer du sein